logo
Plus   Neg
Share
Email

Teva Launches Generic Version Of Uceris In U.S.

Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Uceris 1 or budesonide extended-release tablets, 9 mg, in the U.S.

Budesonide extended-release tablets are a glucocorticosteroid indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis.

Uceris had annual sales of about $196 million in the U.S., according to IMS data as of May 2018.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

24 Articles
Editors Pick
Micro-blogging site Twitter Inc. (TWTR) Tuesday reported a surge in its first-quarter profit. Both earnings and revenues beat analysts' estimates, sending shares up by 6 percent in the pre-market trading. But, Twitter's average monthly active users or MAU figure declined from last year. Verizon Communications Inc. on Tuesday reported a nearly 11 percent increase in profit for the first quarter from last year on higher wireless revenues and flat expenses. Adjusted earnings per share for the quarter beat analysts' estimates, while revenues were in-line with expectations. Looking ahead, the company raised its adjusted earnings outlook for fiscal 2019. While reporting financial results for the third quarter, consumer goods giant Procter & Gamble Co. (PG) on Tuesday maintained its full-year 2019 guidance for earnings per share and core earnings per share growth, while raising its outlook for all-in sales growth and organic sales growth for the year. For...
Follow RTT